These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 7242300)
1. [Mali children antipoliomyelitic immunity before and after two oral immunizations against poliomyelitis (author's transl)]. Fofana Y; Ehrengut W; Koch I; Allerdist H; Diallo D Med Trop (Mars); 1981; 41(2):151-5. PubMed ID: 7242300 [TBL] [Abstract][Full Text] [Related]
3. [Poliomyelitis in New Caledonia: epidemiological data, post-vaccinal seroconversion, prophylactic strategy]. Louis JP; Panon G; Le Gonidec G Med Trop (Mars); 1985; 45(3):223-33. PubMed ID: 2999557 [TBL] [Abstract][Full Text] [Related]
4. Antibody to poliovirus in older children and young adults in Israel and the use of poliovaccines for the immunization of the seronegatives. Goldblum N; Kra-Oz Z; Swartz T Dev Biol Stand; 1979; 43():173-7. PubMed ID: 230108 [TBL] [Abstract][Full Text] [Related]
5. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys]. Zabicka J Przegl Epidemiol; 1981; 35(3):385-9. PubMed ID: 6276928 [No Abstract] [Full Text] [Related]
6. [Status of immunity against poliomyelitis. Polio serosurvey in 1993]. Diedrich S; Schreier E Dtsch Med Wochenschr; 1995 Feb; 120(8):239-44. PubMed ID: 7867480 [TBL] [Abstract][Full Text] [Related]
7. [Serum conversion rate following oral poliomyelitis immunization in Mali, Africa 1982]. Ehrengut W; AgRhaly A; Koch I; Koumaré B; Simaga SY; Diallo D Monatsschr Kinderheilkd; 1984 Jan; 132(1):29-31. PubMed ID: 6321963 [TBL] [Abstract][Full Text] [Related]
8. Anomalous observations on IPV and OPV vaccination. John TJ Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328 [TBL] [Abstract][Full Text] [Related]
9. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies. Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641 [TBL] [Abstract][Full Text] [Related]
10. Neutralizing antibodies against poliovirus serotypes among children in southwest Nigeria. Adewumi MO; Donbraye E; Odaibo GN; Bakarey AS; Opaleye OO; Olaleye DO J Trop Pediatr; 2006 Apr; 52(2):92-5. PubMed ID: 16014758 [TBL] [Abstract][Full Text] [Related]
11. Immunity status to polioviruses among non-European union immigrants in Veneto Region (North-East Italy). Trivello R; Ngatchu T; Marin V; Moretti G; Malatesta R; Maini P; Moschen ME; Baldo V; De Marzi L; Majori S; Puppo A; Renzulli G Ann Clin Lab Sci; 1996; 26(2):154-9. PubMed ID: 8852425 [TBL] [Abstract][Full Text] [Related]
12. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion. Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277 [TBL] [Abstract][Full Text] [Related]
13. Immunity status of Czech population with regard to poliomyelitis in 1970--1975. Teplý V; Srámová H; Skrídlovská E; Strnad P J Hyg Epidemiol Microbiol Immunol; 1977; 21(3):315-23. PubMed ID: 564368 [TBL] [Abstract][Full Text] [Related]
14. Poliomyelitis: epidemiology and prophylaxis. 4. Serological and virological surveys conducted after a mass vaccination campaign for the control of a threatening poliomyelitis epidemic. Metselaar D; McDonald K; Gemert W; Nottay B; Muli JM Bull World Health Organ; 1977; 55(6):747-53. PubMed ID: 202417 [TBL] [Abstract][Full Text] [Related]
15. Seroimmunity to poliomyelitis in Sweden after the use of inactivated poliovirus vaccine for 10 years. Böttiger M; Zetterberg B; Salenstedt CR Bull World Health Organ; 1972; 46(2):141-9. PubMed ID: 4537478 [TBL] [Abstract][Full Text] [Related]
16. Immunity status to poliovirus in Veneto region (north-east Italy). A seroepidemiological survey. Trivello R; Farisano G; Bonello C; Moschen ME; Baldo V; Majori S; Moretti G; Marin V; Piron L; Renzulli G Ann Clin Lab Sci; 1994; 24(6):542-7. PubMed ID: 7847782 [TBL] [Abstract][Full Text] [Related]
17. [Immunity against poliomyelitis in the German Federal Republic (author's transl)]. Doerr HW; Glück H; Esser I; Firtzlaff R; Koch I; Maass G; May G; Meier-Ewert H; Neumann-Haefelin D; Thraenhart O; Wecker I Dtsch Med Wochenschr; 1979 Jul; 104(30):1065-7. PubMed ID: 467253 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan. Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes. Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770 [TBL] [Abstract][Full Text] [Related]